TRAF6 and hepatocellular carcinoma: Indeed, the expression of TLR9 and TRAF6, downstream targets of the TLR9 signaling, were increased after CM from HCC cells pre-treated with sorafenib and mtDNA treatment (Fig. 6B and D).